Net profit of Caplin Point Laboratories rose 17.93% to Rs 163.88 crore in the quarter ended December 2025 as against Rs 138.96 crore during the previous quarter ended December 2024. Sales rose 10.10% to Rs 542.77 crore in the quarter ended December 2025 as against Rs 492.96 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 542.77 | 492.96 | 10 |
| OPM % | 34.94 | 32.92 | - |
| PBDT | 223.17 | 193.46 | 15 |
| PBT | 203.89 | 177.26 | 15 |
| NP | 163.88 | 138.96 | 18 |